High recurrence of reintervention for anastomotic dehiscence or new perforations was observed. The use of negative pressure treatment was never reported. Open abdomen treatment allows the reduction of contamination by gastrointestinal contents decreasing the risk of abdominal

collections, favors rapid evidence of hemorrhage permitting a prompt control of the bleeding source, offers temporary abdominal closure, helps ICU care and delays definitive surgery [23, 24]. In this case we performed an open abdomen treatment to better remove the losses and control possible sources of new perforations, without needing of bowel resection. The mesh-mediated fascial traction technique combined with negative pressure treatment allowed to preserve the fascia, and to obtain the fascial primarily closure. As reported in literature, achievement of fascial Selleck MK 8931 closure has significant implications for the recovery of the patients, reducing ICU and hospital length of stay, and need for surgical reconstruction of the abdominal wall [25]. We had to perform a bowel deviation because Selleckchem Captisol of the critical ischemic vasculitis of the duodenum. To reduce the amount of biliary leakage and to obtain a faster outcome, we positioned a PTBD. Using this composite technique progressive fistula flow reduction was obtained, allowing abdominal closure after

two months and PTBD removal after four months. Conclusions When clinical findings and symptoms suggest possible abdominal vasculitis in a young subject known for DM, it is very important to consider bowel and particularly duodenal perforation. We found Interleukin-3 receptor very helpful CT scan with oral contrast to support diagnosis and we had to face the more life-threatening condition of multiple ischemic intestinal TPCA-1 molecular weight ulcerations conditioning duodenal multiple perforations. To manage this challenging condition we used open abdomen treatment with exclusion of the duodenal ischemic perforated tract through a gastroenteroanastomosis

and PTBD with the creation of a guided fistula to decrease the flow and obtaining progressive healing with improvement of patient’s general conditions. This surgical treatment must always be accompanied by DM specific medical treatment to avoid further vasculitic complications and to obtain control of the disease activity. Consent Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. References 1. Ebert EC: Review article: the gastrointestinal complication of myositis. Aliment Pharmacol Ther 2009,31(3):359–365.PubMedCrossRef 2. Lin WY, Wang SJ, Hwang DW, Lan JL, Yeh SH: Technetium-99 m-Pyrophosphate scintigraphic finding of intestinal perforation in dermatomyositis. J Nucl Med 1995,36(9):1615–1617.PubMed 3.